Abstract:Objective To evaluate the expressions of cathepsin-D(Cath-D)and matrix metalloproteinase-9(MMP-9)in bladder transitional cell carcinoma(BTCC)and to determine their relationship with clinic pathological characters,recurrence metastasis and survival.Method Immunohistochemistry was used to detect the expressions of Cath-D and MMP-9 in 60 tissues of BTCC and 10 tissues of normal mucosa of bladder.Results The expressions of Cath-D and MMP-9 were all weakly or strongly positive in 60 tissues of BTCC,and the stongly positivity rate of Cath-D and MMP-9 in BTCC were 45% and 38.3%;while in normal controls all were weakly positive or negative.The strongly positive rate of Cath-D in BTCC closely correlated with higher clinicalstages(P 0.05)and postoperative recurrence(P 0.05).The strongly positive rate of MMP-9 in BTCC closely correlated with poorly pathologicalgrades(P 0.05),higher clinicalstages(P 0.05)and postoperative recurrence(P 0.05).The postoperative follow-up showed that the group of Cath-D strongly positive had a higher risk of recurrence/metastasis and a lower survival rat than the group of weakly positive,and so did the group of MMP-9 strongly positive.The analyse of Spearman rank correlation showed that the expressions of Cath-D and MMP-9 closely correlated with each other(r =0.458,P 0.01).In T3～T4 and poorly differentiated BTCC,the rat of both Cath-D and MMP-9 strongly positive was higher than the rate of Cath-D or MMP-9 separately strongly positive,and also higher than the rate of both Cath-D and MMP-9 weakly positive.The group of both Cath-D and MMP-9 strongly positive had a higher risk of recurrence/metastasis and a lower survival rate than the group of Cath-D or MMP-9 separately strongly positive,and the group of both Cath-D and MMP-9 weakly positive.Conclusions The expression of Cath-D and MMP-9 closely correlated with the clinical stage and pathological grade of BTCC,and affected the risk of recurrence/metastasis and the prognosis of BTCC.It was suggested that they may be of great value in predicting the prognosis of patients with BTCC.

Expression of KAI1/CD_(82) and MRP-1/CD_9 in transitional cell carcinoma of bladder

Expression of KAI1/CD82 and MRP-1/CD9 in Transitional Cell Carcinoma of Bladder

Expressions of cyclooxygenase-2 and epidermal growth factor receptor in transitional cell carcinoma of bladder and their correlation

Expressions of Cath-D and MMP-9 Associated with Recurrence Metastasis and Prognosis of Bladder Transitional Cell Carcinoma

Expression of MMP-9 in Transitional Cell Carcinoma of Bladder and Its Significance

Clinical Significance of MACC1, Twist1, and KAI1 Expressions in Infiltrating Urothelial Carcinoma of the Bladder.

Expression of RASSF1A, cyclin D1, Bcl-2 and their significance in transitional cell carcinoma fo bladder

Expression and Clinical Significance of Matrix Metalloproteinase-2,9 in Transitional Cell Bladder Carcinoma

The Expression and Significance of TEP1 and CDK4 Proteins in Bladder Carcinoma

Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma

Expression of X-linked Inhibitor of Apoptosis Protein in Transitional Cell Carcinoma and the Clinical Significance

Expression of E-Cadherin and Α-Catenin in Bladder Transitional Cell Carcinoma and Its Clinical Significance

Expressions of RASSF1A,Cyclin D1,Bcl-2 and Their Significance in Transitional Cell Carcinoma of Bladder

Expressions of Matrix Metalloproteinases-9 and Its Tissue Inhibitor TIMP-1 in Carcinoma of Bladder and Significances

Expression of Erythropoietin and Its Receptor in Transitional Cell Carcinoma of Bladder

The expression analysis and its clinical significance of CST1 in bladder translational cell carcinoma

Clinical Significance of Transforming Growth Factor Β_1 in Human Bladder Transitional Cell Carcinomas

[Expression and Clinical Significance of Nuclear Matrix Protein 22 and Cytokeratin 18 in Transitional Cell Carcinoma of the Bladder].

CK20 and Ki-67 As Significant Prognostic Factors in Human Bladder Carcinoma

Expression of survivin and bcl-2 and their correlation in transitional cell carcinoma of the bladder

The Clinical Significance of KAI1/CD82 Expression in Colon Tumor